Press release
Geographic Atrophy Market 2033: Breakthrough AMD Treatments Reshape Care | United States, APAC, GCC & MENA
Geographic Atrophy Market Size 2026-2033
Find the right strategic partners to accelerate your business. Get started today:- https://www.datamintelligence.com/partner-identification-enquiry/geographic-atrophy-market?kb
United States: Recent Industry Developments
✅ July 2026: Johnson & Johnson discontinued development of its investigational gene therapy JNJ-1887 for geographic atrophy after reviewing Phase 2b PARASOL study results.
✅ July 2026: Astellas presented new clinical and real-world data for IZERVAY® (avacincaptad pegol) and its investigational ASP7317 retinal cell therapy at the ASRS 2026 Annual Meeting, highlighting continued innovation in geographic atrophy treatment.
✅ June 2026: Belite Bio completed the rolling NDA submission to the U.S. FDA for tinlarebant and continued advancement of its Phase 3 PHOENIX trial for geographic atrophy.
✅ May 2026: Belite Bio confirmed continued progress in its global geographic atrophy clinical program, including upcoming Phase 3 milestones and commercial launch planning.
Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/geographic-atrophy-market?kb
Top Investing Companies (2026):
Apellis Pharmaceuticals, Inc. (US), Iveric Bio (US), Alkeus Pharmaceuticals, Inc. (US), Allegro Ophthalmics, LLC (US), Stealth BioTherapeutics (Cayman Islands), Gyroscope Therapeutics Limited (UK), Regenerative Patch Technologies, LLC (US), Hoffmann-La Roche AG (Switzerland), Genentech, Inc. (US), and NGM Biopharmaceuticals Inc. (US)
Geographic Atrophy Market Latest Treatments 2026:
Pegcetacoplan and avacincaptad pegol remained the only FDA-approved GA treatments in 2026, both continuing to slow lesion growth while carrying a risk of conversion to neovascular AMD.
The most visible new treatment signal in early 2026 was Ocugen's OCU410 gene-therapy data, which reported a 31% reduction in lesion growth at 12 months in Phase 2 ArMaDa.
Another early-2026 development was Complement Therapeutics' CTx001, which received FDA Fast Track designation in January 2026.
Key Strategic Forecasting in 2026:
The Global Geographic Atrophy Market is projected to experience strong growth throughout the 2026-2033. In 2025, the market is expected to unlock significant opportunities across the value chain as organizations prioritize operational efficiency, asset reliability, and cost optimization. The latest market outlook provides comprehensive insights into emerging trends, competitive developments, investment opportunities, and evolving business strategies, equipping organizations with the intelligence needed to identify new revenue streams, strengthen market positioning, and make confident long-term strategic Investment in the rapidly evolving Geographic Atrophy industry.
Key Investment Developments 2026:
In June 2026, Apellis Pharmaceuticals, Inc. announced new real-world evidence highlighting the long-term effectiveness of SYFOVRE® (pegcetacoplan) in slowing geographic atrophy lesion progression, reinforcing confidence among retina specialists.
In April 2026, Astellas Pharma Inc. presented additional clinical and real-world data for IZERVAY® (avacincaptad pegol), demonstrating sustained reduction in geographic atrophy progression and continued safety across treated patients.
In March 2026, Roche Holding AG (Genentech) expanded research collaborations focused on next-generation retinal imaging and biomarker development to improve early diagnosis and treatment monitoring for geographic atrophy.
In February 2026, Alkeus Pharmaceuticals reported positive progress in the clinical development of ALK-001, advancing its investigational therapy for geographic atrophy associated with age-related macular degeneration through ongoing late-stage studies.
How Our Market Research Process Works:
The Global Geographic Atrophy Market report delivers strategic insights into market trends, competitive dynamics, investment opportunities, regulatory developments, and emerging technologies. Backed by comprehensive primary and secondary research, it equips organizations with actionable intelligence to identify growth opportunities, manage market risks, and make confident business decisions in an evolving industry.
Growing M&A/partnerships 2026:
• May 2026: Biogen completed its acquisition of Apellis Pharmaceuticals, adding the geographic atrophy therapy SYFOVRE® (pegcetacoplan) to its ophthalmology portfolio.
Unlock the Full 360° Strategic Market Report & Make Smarter Business Decisions: https://www.datamintelligence.com/buy-now-page?report=geographic-atrophy-market?kb
Japan: Recent Industry Developments
✅ July 2026: Astellas highlighted new geographic atrophy research at the ASRS 2026 Annual Meeting, including long-term IZERVAY® analyses and preliminary Phase 1b data for ASP7317 retinal pigment epithelium cell therapy.
✅ June 2026: Belite Bio continued advancing tinlarebant for geographic atrophy, supported by Japan's Sakigake Designation to accelerate future regulatory review.
✅ June 2026: Santen Pharmaceutical continued expanding its ophthalmology innovation strategy through global licensing and development collaborations supporting advanced retinal disease therapies.
✅ January 2026: Astellas continued the conditional commercialization of IZERVAY® in Japan while expanding clinical evidence generation for geographic atrophy treatment.
Major Strategic Segmentation Opportunities 2026:
By Treatment Type: Medication (Pegcetacoplan), AREDS2 Supplements, Implantable Miniature Telescope (IMT)
By Age Group: Above 60 Years, Above 75 Years
By End Users: Hospitals, Specialty Clinics, Others
Regional Growth for Market:
⇥ North America - Leading market driven by high awareness of age-related macular degeneration (AMD), strong adoption of newly approved geographic atrophy therapies, advanced retinal care infrastructure, and favorable reimbursement policies.
⇥ Europe - Growth supported by an aging population, increasing diagnosis of geographic atrophy, expanding access to ophthalmology services, and rising adoption of innovative retinal treatments.
⇥ Asia-Pacific - Expanding rapidly due to a growing elderly population, increasing prevalence of retinal disorders, improving healthcare infrastructure, and greater investment in ophthalmic diagnostics and treatment.
⇥ Middle East & Africa - Emerging market supported by improving access to specialized eye care, rising awareness of retinal diseases, and government initiatives to strengthen ophthalmology services.
⇥ Latin America - Gradual growth fueled by increasing healthcare expenditure, expanding retinal disease screening programs, improving access to ophthalmologists, and growing adoption of advanced treatment options.
Request Strategic Market Customization: https://datamintelligence.com/customize/geographic-atrophy-market?kb
Global Market Drivers 2026:
Rising Aging Population: The increasing global elderly population is driving higher prevalence of geographic atrophy, expanding the demand for effective diagnosis and treatment options.
Growing Approval of Novel Therapies: Recent regulatory approvals of complement inhibitor therapies are improving treatment availability and encouraging wider adoption in clinical practice.
Advancements in Retinal Imaging: Innovations in OCT, fundus autofluorescence, and AI-assisted diagnostics enable earlier detection and better disease monitoring, supporting market growth.
Increasing Healthcare Awareness and R&D Investments: Greater awareness of age-related macular degeneration (AMD) alongside strong investments in ophthalmology research is accelerating the development of next-generation geographic atrophy therapies.
Get Customized Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Geographic Atrophy Market 2033: Breakthrough AMD Treatments Reshape Care | United States, APAC, GCC & MENA here
News-ID: 4588645 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Benzoxazine Prepreg Market Set for Strong Growth Across Automotive and Transport …
DataM Intelligence has unveiled its latest "Benzoxazine Prepreg Market Size 2026" report, delivering strategic market intelligence for organizations seeking to capitalize on emerging growth opportunities and gain a competitive edge. The report provides in-depth analysis of market size, revenue forecasts, CAGR, regional dynamics, segment-level performance, competitive landscape, investment trends, and technological advancements shaping the industry. It offers valuable insights into market drivers, future opportunities, strategic developments, and evolving customer demand,…
Grid-Scale Battery Market Set for Explosive Growth to USD 107.29 Billion by 2035 …
The Grid-Scale Battery Market reached USD 10.82 billion in 2025 and is projected to grow to approximately USD 107.29 billion by 2035, growing at a CAGR of 25.74% during the forecast period (2026-2035).
The market is witnessing strong momentum as utilities, grid operators, and governments accelerate investments in large-scale energy storage to strengthen grid reliability, integrate renewable energy sources, and improve power system flexibility. Rising deployment of solar and wind power,…
Powder Coating Market Set to Hit US$ 31.28 Billion by 2035, Automotive and Const …
The Powder Coating Market reached US$ 16.28 billion in 2025 and is expected to reach US$ 31.28 billion by 2035, growing at a CAGR of 6.75% during the forecast period 2026-2035.
The market is witnessing steady expansion as manufacturers across automotive, construction, appliances, furniture, and industrial equipment increasingly adopt powder coatings for their durability, low volatile organic compound (VOC) emissions, and cost-efficient application processes. Stringent environmental regulations and the transition toward…
Black Soldier Fly Market Set to Transform Animal Feed & AgriTech | United States …
DataM Intelligence has unveiled its latest "Black Soldier Fly Market Size 2026" report, delivering strategic market intelligence for organizations seeking to capitalize on emerging growth opportunities and gain a competitive edge. The report provides in-depth analysis of market size, revenue forecasts, CAGR, regional dynamics, segment-level performance, competitive landscape, investment trends, and technological advancements shaping the industry. It offers valuable insights into market drivers, future opportunities, strategic developments, and evolving customer…
More Releases for Geographic
Geographic Information System (GIS) Software Global Market Report 2024 - Geograp …
"The Business Research Company recently released a comprehensive report on the Global Geographic Information System (GIS) Software Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The…
Cybersecurity Market Regional Analysis | Evaluating Geographic Trends
Cybersecurity Market Scope and Overview
In the digital era, where information is the new currency, cybersecurity emerges as a paramount concern for individuals, businesses, and governments alike. With the exponential growth of cyber threats, the global Cybersecurity Market has witnessed a surge in demand for innovative solutions and services to safeguard sensitive data and critical infrastructure. This report delves into a comprehensive analysis of the cybersecurity market, covering key players, market…
Geographic Information System - Comprehensive Analysis
GIS is used to power millions of decisions every day all over the world, such as examining crime patterns, pinpointing novel store locations, directing in-car navigation, and predicting and forecasting the weather, among others. The growing demand for location-based analytics among businesses to enhance operational efficiency and improve decision-making is driving the market growth. Similarly, the necessity to combine traditional data with three-dimensional data to get valuable insights from location-based…
Automobile Accessories Market: Charting New Geographic Territory
An extensive analysis of the Automobile Accessories market strategy of the leading companies in the precision of import/export consumption, supply and demand figures, cost, price, revenue and gross margins. The report starts by an introduction about the company profiling and a comprehensive review about the strategy concept and the tools that can be used to assess and analyze strategy. It also analyzes the company’s strategy in the light of Porter’s…
Geographic Atrophy - Pipeline Review, H2 2018 - ResearchByMarkets.com
"Geographic Atrophy - Pipeline Review, H2 2018", provides an overview of the Geographic Atrophy (Ophthalmology) pipeline landscape.
Geographic atrophy is an advanced form of age-related macular degeneration that can result in the progressive and irreversible loss of retina which can lead to a loss of visual function over time. Symptoms include difficulty during reading. Risk factors include smoking, thyroid hormones or antacids and in patients with coronary heart diseases and cataract…
MapsOfWorld.com partners with National Geographic Maps
MapsOfWorld.com has proudly partnered with National Geographic Maps to sell National Geographic maps and atlases in the United States. All wall maps are available at an initial discount of 15%, along with additional discounts on bulk items ordered by corporations and schools. Range of products available for sale include: paper and laminated wall maps, mural (wall paper) maps, travel maps and atlases. Wall maps are available in National Geographic’s three…
